nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—Cytochrome P450 3A Inducers—Nevirapine—acquired immunodeficiency syndrome	0.122	0.209	CiPCiCtD
Phenytoin—Cytochrome P450 2B6 Inducers—Nevirapine—acquired immunodeficiency syndrome	0.102	0.175	CiPCiCtD
Phenytoin—Cytochrome P450 3A Inducers—Efavirenz—acquired immunodeficiency syndrome	0.0973	0.167	CiPCiCtD
Phenytoin—Cytochrome P450 3A Inducers—Ritonavir—acquired immunodeficiency syndrome	0.0973	0.167	CiPCiCtD
Phenytoin—Cytochrome P450 2C19 Inducers—Ritonavir—acquired immunodeficiency syndrome	0.0814	0.14	CiPCiCtD
Phenytoin—Cytochrome P450 2B6 Inducers—Efavirenz—acquired immunodeficiency syndrome	0.0814	0.14	CiPCiCtD
Phenytoin—ALB—acquired immunodeficiency syndrome	0.0737	1	CbGaD
Phenytoin—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.00768	0.0298	CbGbCtD
Phenytoin—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.00674	0.0262	CbGbCtD
Phenytoin—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.00674	0.0262	CbGbCtD
Phenytoin—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.00665	0.0258	CbGbCtD
Phenytoin—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.00625	0.0243	CbGbCtD
Phenytoin—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.00625	0.0243	CbGbCtD
Phenytoin—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.00594	0.0231	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.00594	0.0231	CbGbCtD
Phenytoin—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.00566	0.022	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.00513	0.0199	CbGbCtD
Phenytoin—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.00513	0.0199	CbGbCtD
Phenytoin—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.005	0.0194	CbGbCtD
Phenytoin—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.00498	0.0193	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.00498	0.0193	CbGbCtD
Phenytoin—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00493	0.0191	CbGbCtD
Phenytoin—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.00474	0.0184	CbGbCtD
Phenytoin—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0045	0.0175	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0045	0.0175	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0045	0.0175	CbGbCtD
Phenytoin—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0045	0.0175	CbGbCtD
Phenytoin—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00446	0.0173	CbGbCtD
Phenytoin—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00446	0.0173	CbGbCtD
Phenytoin—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.00429	0.0166	CbGbCtD
Phenytoin—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00428	0.0166	CbGbCtD
Phenytoin—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00428	0.0166	CbGbCtD
Phenytoin—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00423	0.0164	CbGbCtD
Phenytoin—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0042	0.0163	CbGbCtD
Phenytoin—ALB—Zidovudine—acquired immunodeficiency syndrome	0.00403	0.0156	CbGbCtD
Phenytoin—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00397	0.0154	CbGbCtD
Phenytoin—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00385	0.0149	CbGbCtD
Phenytoin—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00373	0.0145	CbGbCtD
Phenytoin—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00359	0.014	CbGbCtD
Phenytoin—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00359	0.014	CbGbCtD
Phenytoin—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00351	0.0136	CbGbCtD
Phenytoin—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00338	0.0131	CbGbCtD
Phenytoin—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00338	0.0131	CbGbCtD
Phenytoin—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0033	0.0128	CbGbCtD
Phenytoin—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0033	0.0128	CbGbCtD
Phenytoin—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00325	0.0126	CbGbCtD
Phenytoin—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00325	0.0126	CbGbCtD
Phenytoin—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00321	0.0125	CbGbCtD
Phenytoin—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00311	0.0121	CbGbCtD
Phenytoin—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0031	0.012	CbGbCtD
Phenytoin—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00301	0.0117	CbGbCtD
Phenytoin—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00299	0.0116	CbGbCtD
Phenytoin—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00299	0.0116	CbGbCtD
Phenytoin—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0029	0.0113	CbGbCtD
Phenytoin—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00272	0.0106	CbGbCtD
Phenytoin—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00272	0.0106	CbGbCtD
Phenytoin—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00261	0.0101	CbGbCtD
Phenytoin—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00258	0.01	CbGbCtD
Phenytoin—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0025	0.00972	CbGbCtD
Phenytoin—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0025	0.00972	CbGbCtD
Phenytoin—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00243	0.00944	CbGbCtD
Phenytoin—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00226	0.00879	CbGbCtD
Phenytoin—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00226	0.00879	CbGbCtD
Phenytoin—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0022	0.00853	CbGbCtD
Phenytoin—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0022	0.00853	CbGbCtD
Phenytoin—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00217	0.00843	CbGbCtD
Phenytoin—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00211	0.00818	CbGbCtD
Phenytoin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00204	0.00793	CbGbCtD
Phenytoin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00192	0.00746	CbGbCtD
Phenytoin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00192	0.00746	CbGbCtD
Phenytoin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00174	0.00675	CbGbCtD
Phenytoin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00174	0.00675	CbGbCtD
Phenytoin—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00163	0.00633	CbGbCtD
Phenytoin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00582	CbGbCtD
Phenytoin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00146	0.00565	CbGbCtD
Phenytoin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.00511	CbGbCtD
Phenytoin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00132	0.00511	CbGbCtD
Phenytoin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00126	0.0049	CbGbCtD
Phenytoin—SCN8A—nerve—acquired immunodeficiency syndrome	0.00115	0.0745	CbGeAlD
Phenytoin—CYP11B1—blood—acquired immunodeficiency syndrome	0.000412	0.0267	CbGeAlD
Phenytoin—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000341	0.0221	CbGeAlD
Phenytoin—CYP2C18—digestive system—acquired immunodeficiency syndrome	0.000309	0.02	CbGeAlD
Phenytoin—SCN8A—spinal cord—acquired immunodeficiency syndrome	0.000307	0.0199	CbGeAlD
Phenytoin—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000298	0.0193	CbGeAlD
Phenytoin—CYP2C18—vagina—acquired immunodeficiency syndrome	0.000272	0.0176	CbGeAlD
Phenytoin—SCN9A—spinal cord—acquired immunodeficiency syndrome	0.00027	0.0175	CbGeAlD
Phenytoin—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000269	0.0174	CbGeAlD
Phenytoin—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000267	0.0173	CbGeAlD
Phenytoin—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000264	0.0171	CbGeAlD
Phenytoin—SLCO1C1—spinal cord—acquired immunodeficiency syndrome	0.000262	0.017	CbGeAlD
Phenytoin—SCN8A—nervous system—acquired immunodeficiency syndrome	0.000259	0.0168	CbGeAlD
Phenytoin—SCN8A—central nervous system—acquired immunodeficiency syndrome	0.000249	0.0161	CbGeAlD
Phenytoin—SCN9A—lung—acquired immunodeficiency syndrome	0.000246	0.0159	CbGeAlD
Phenytoin—SCN1A—spinal cord—acquired immunodeficiency syndrome	0.000232	0.015	CbGeAlD
Phenytoin—SCN2A—blood—acquired immunodeficiency syndrome	0.000221	0.0143	CbGeAlD
Phenytoin—SLCO1C1—nervous system—acquired immunodeficiency syndrome	0.000221	0.0143	CbGeAlD
Phenytoin—SCN2A—spinal cord—acquired immunodeficiency syndrome	0.000213	0.0138	CbGeAlD
Phenytoin—SLCO1C1—central nervous system—acquired immunodeficiency syndrome	0.000213	0.0138	CbGeAlD
Phenytoin—SCN1A—lung—acquired immunodeficiency syndrome	0.000211	0.0137	CbGeAlD
Phenytoin—SCN2A—vagina—acquired immunodeficiency syndrome	0.000205	0.0133	CbGeAlD
Phenytoin—SCN5A—digestive system—acquired immunodeficiency syndrome	0.000203	0.0132	CbGeAlD
Phenytoin—SCN4A—nervous system—acquired immunodeficiency syndrome	0.000203	0.0131	CbGeAlD
Phenytoin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000202	0.0131	CbGeAlD
Phenytoin—SCN8A—brain—acquired immunodeficiency syndrome	0.000198	0.0128	CbGeAlD
Phenytoin—SCN1A—nervous system—acquired immunodeficiency syndrome	0.000196	0.0127	CbGeAlD
Phenytoin—SCN4A—central nervous system—acquired immunodeficiency syndrome	0.000195	0.0127	CbGeAlD
Phenytoin—SCN3A—blood—acquired immunodeficiency syndrome	0.000194	0.0126	CbGeAlD
Phenytoin—SCN5A—blood—acquired immunodeficiency syndrome	0.000194	0.0126	CbGeAlD
Phenytoin—SCN1A—central nervous system—acquired immunodeficiency syndrome	0.000188	0.0122	CbGeAlD
Phenytoin—SCN3A—bone marrow—acquired immunodeficiency syndrome	0.000188	0.0122	CbGeAlD
Phenytoin—SCN3A—spinal cord—acquired immunodeficiency syndrome	0.000187	0.0121	CbGeAlD
Phenytoin—SCN3A—vagina—acquired immunodeficiency syndrome	0.00018	0.0117	CbGeAlD
Phenytoin—SCN5A—vagina—acquired immunodeficiency syndrome	0.00018	0.0116	CbGeAlD
Phenytoin—SCN2A—nervous system—acquired immunodeficiency syndrome	0.00018	0.0116	CbGeAlD
Phenytoin—SCN9A—brain—acquired immunodeficiency syndrome	0.000174	0.0113	CbGeAlD
Phenytoin—SCN2A—central nervous system—acquired immunodeficiency syndrome	0.000173	0.0112	CbGeAlD
Phenytoin—SCN3A—lung—acquired immunodeficiency syndrome	0.00017	0.011	CbGeAlD
Phenytoin—SLCO1C1—brain—acquired immunodeficiency syndrome	0.000169	0.0109	CbGeAlD
Phenytoin—SCN9A—lymph node—acquired immunodeficiency syndrome	0.000168	0.0109	CbGeAlD
Phenytoin—SLCO1C1—lymph node—acquired immunodeficiency syndrome	0.000163	0.0106	CbGeAlD
Phenytoin—SCN3A—nervous system—acquired immunodeficiency syndrome	0.000158	0.0102	CbGeAlD
Phenytoin—SCN5A—nervous system—acquired immunodeficiency syndrome	0.000157	0.0102	CbGeAlD
Phenytoin—SCN4A—brain—acquired immunodeficiency syndrome	0.000155	0.01	CbGeAlD
Phenytoin—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000153	0.00989	CbGeAlD
Phenytoin—SCN3A—central nervous system—acquired immunodeficiency syndrome	0.000152	0.00984	CbGeAlD
Phenytoin—SCN5A—central nervous system—acquired immunodeficiency syndrome	0.000151	0.00981	CbGeAlD
Phenytoin—SCN1A—brain—acquired immunodeficiency syndrome	0.00015	0.00969	CbGeAlD
Phenytoin—ABCC2—blood—acquired immunodeficiency syndrome	0.000145	0.00942	CbGeAlD
Phenytoin—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000143	0.00925	CbGeAlD
Phenytoin—SCN2A—brain—acquired immunodeficiency syndrome	0.000137	0.00889	CbGeAlD
Phenytoin—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000131	0.0085	CbGeAlD
Phenytoin—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000128	0.00832	CbGeAlD
Phenytoin—CYP2C19—blood—acquired immunodeficiency syndrome	0.000125	0.00809	CbGeAlD
Phenytoin—SCN3A—brain—acquired immunodeficiency syndrome	0.000121	0.00781	CbGeAlD
Phenytoin—SCN5A—brain—acquired immunodeficiency syndrome	0.00012	0.00779	CbGeAlD
Phenytoin—SCN3A—lymph node—acquired immunodeficiency syndrome	0.000117	0.00755	CbGeAlD
Phenytoin—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000116	0.0075	CbGeAlD
Phenytoin—CYP2C8—blood—acquired immunodeficiency syndrome	0.000109	0.00706	CbGeAlD
Phenytoin—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000104	0.00673	CbGeAlD
Phenytoin—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000103	0.00669	CbGeAlD
Phenytoin—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000103	0.00665	CbGeAlD
Phenytoin—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000102	0.00659	CbGeAlD
Phenytoin—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000101	0.00655	CbGeAlD
Phenytoin—CYP3A5—blood—acquired immunodeficiency syndrome	9.84e-05	0.00638	CbGeAlD
Phenytoin—CYP2B6—blood—acquired immunodeficiency syndrome	9.78e-05	0.00634	CbGeAlD
Phenytoin—CYP2C9—blood—acquired immunodeficiency syndrome	9.69e-05	0.00627	CbGeAlD
Phenytoin—ALB—brain—acquired immunodeficiency syndrome	9.63e-05	0.00624	CbGeAlD
Phenytoin—ALB—lymph node—acquired immunodeficiency syndrome	9.3e-05	0.00603	CbGeAlD
Phenytoin—CYP3A5—vagina—acquired immunodeficiency syndrome	9.12e-05	0.00591	CbGeAlD
Phenytoin—CYP2B6—vagina—acquired immunodeficiency syndrome	9.07e-05	0.00587	CbGeAlD
Phenytoin—ABCC2—lymph node—acquired immunodeficiency syndrome	8.72e-05	0.00565	CbGeAlD
Phenytoin—CYP3A5—lung—acquired immunodeficiency syndrome	8.63e-05	0.00559	CbGeAlD
Phenytoin—CYP2B6—lung—acquired immunodeficiency syndrome	8.57e-05	0.00555	CbGeAlD
Phenytoin—Fosphenytoin—ALB—acquired immunodeficiency syndrome	8.45e-05	0.436	CrCbGaD
Phenytoin—CYP2B6—nervous system—acquired immunodeficiency syndrome	7.94e-05	0.00514	CbGeAlD
Phenytoin—ABCB1—retina—acquired immunodeficiency syndrome	7.82e-05	0.00506	CbGeAlD
Phenytoin—CYP3A4—digestive system—acquired immunodeficiency syndrome	7.75e-05	0.00502	CbGeAlD
Phenytoin—CYP2B6—central nervous system—acquired immunodeficiency syndrome	7.64e-05	0.00495	CbGeAlD
Phenytoin—CYP3A4—blood—acquired immunodeficiency syndrome	7.39e-05	0.00478	CbGeAlD
Phenytoin—CYP2C8—brain—acquired immunodeficiency syndrome	6.77e-05	0.00438	CbGeAlD
Phenytoin—CYP2B6—brain—acquired immunodeficiency syndrome	6.07e-05	0.00393	CbGeAlD
Phenytoin—CYP3A4—nervous system—acquired immunodeficiency syndrome	6e-05	0.00388	CbGeAlD
Phenytoin—Phenprocoumon—ALB—acquired immunodeficiency syndrome	5.79e-05	0.299	CrCbGaD
Phenytoin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	5.77e-05	0.00374	CbGeAlD
Phenytoin—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	5.56e-05	0.0036	CbGeAlD
Phenytoin—ABCB1—digestive system—acquired immunodeficiency syndrome	5.49e-05	0.00356	CbGeAlD
Phenytoin—ABCB1—blood—acquired immunodeficiency syndrome	5.23e-05	0.00339	CbGeAlD
Phenytoin—Warfarin—ALB—acquired immunodeficiency syndrome	5.14e-05	0.265	CrCbGaD
Phenytoin—ABCB1—bone marrow—acquired immunodeficiency syndrome	5.06e-05	0.00328	CbGeAlD
Phenytoin—ABCB1—spinal cord—acquired immunodeficiency syndrome	5.04e-05	0.00326	CbGeAlD
Phenytoin—ABCB1—vagina—acquired immunodeficiency syndrome	4.85e-05	0.00314	CbGeAlD
Phenytoin—ABCB1—lung—acquired immunodeficiency syndrome	4.58e-05	0.00297	CbGeAlD
Phenytoin—ABCB1—nervous system—acquired immunodeficiency syndrome	4.24e-05	0.00275	CbGeAlD
Phenytoin—ABCB1—central nervous system—acquired immunodeficiency syndrome	4.09e-05	0.00265	CbGeAlD
Phenytoin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	3.43e-05	0.000474	CcSEcCtD
Phenytoin—Cough—Ritonavir—acquired immunodeficiency syndrome	3.41e-05	0.000472	CcSEcCtD
Phenytoin—Headache—Didanosine—acquired immunodeficiency syndrome	3.41e-05	0.000471	CcSEcCtD
Phenytoin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	3.4e-05	0.00047	CcSEcCtD
Phenytoin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	3.4e-05	0.00047	CcSEcCtD
Phenytoin—Shock—Delavirdine—acquired immunodeficiency syndrome	3.4e-05	0.000469	CcSEcCtD
Phenytoin—Malaise—Saquinavir—acquired immunodeficiency syndrome	3.4e-05	0.000469	CcSEcCtD
Phenytoin—Somnolence—Indinavir—acquired immunodeficiency syndrome	3.4e-05	0.000469	CcSEcCtD
Phenytoin—Asthenia—Stavudine—acquired immunodeficiency syndrome	3.39e-05	0.000468	CcSEcCtD
Phenytoin—Convulsion—Ritonavir—acquired immunodeficiency syndrome	3.39e-05	0.000468	CcSEcCtD
Phenytoin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	3.38e-05	0.000468	CcSEcCtD
Phenytoin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	3.38e-05	0.000467	CcSEcCtD
Phenytoin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	3.38e-05	0.000467	CcSEcCtD
Phenytoin—Hypertension—Ritonavir—acquired immunodeficiency syndrome	3.38e-05	0.000467	CcSEcCtD
Phenytoin—Syncope—Saquinavir—acquired immunodeficiency syndrome	3.38e-05	0.000467	CcSEcCtD
Phenytoin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	3.37e-05	0.000466	CcSEcCtD
Phenytoin—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	3.37e-05	0.000466	CcSEcCtD
Phenytoin—Tremor—Lamivudine—acquired immunodeficiency syndrome	3.37e-05	0.000465	CcSEcCtD
Phenytoin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	3.36e-05	0.000465	CcSEcCtD
Phenytoin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	3.35e-05	0.000463	CcSEcCtD
Phenytoin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	3.35e-05	0.000463	CcSEcCtD
Phenytoin—Pruritus—Stavudine—acquired immunodeficiency syndrome	3.34e-05	0.000462	CcSEcCtD
Phenytoin—Asthenia—Abacavir—acquired immunodeficiency syndrome	3.34e-05	0.000461	CcSEcCtD
Phenytoin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	3.34e-05	0.000461	CcSEcCtD
Phenytoin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	3.33e-05	0.000461	CcSEcCtD
Phenytoin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	3.33e-05	0.00046	CcSEcCtD
Phenytoin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	3.33e-05	0.00046	CcSEcCtD
Phenytoin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	3.33e-05	0.00046	CcSEcCtD
Phenytoin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	3.32e-05	0.000459	CcSEcCtD
Phenytoin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	3.32e-05	0.000459	CcSEcCtD
Phenytoin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	3.31e-05	0.000457	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	3.3e-05	0.000456	CcSEcCtD
Phenytoin—Pruritus—Abacavir—acquired immunodeficiency syndrome	3.29e-05	0.000455	CcSEcCtD
Phenytoin—Fatigue—Indinavir—acquired immunodeficiency syndrome	3.29e-05	0.000455	CcSEcCtD
Phenytoin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	3.29e-05	0.000455	CcSEcCtD
Phenytoin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	3.29e-05	0.000455	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	3.29e-05	0.000454	CcSEcCtD
Phenytoin—Cough—Saquinavir—acquired immunodeficiency syndrome	3.29e-05	0.000454	CcSEcCtD
Phenytoin—Constipation—Indinavir—acquired immunodeficiency syndrome	3.27e-05	0.000451	CcSEcCtD
Phenytoin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	3.26e-05	0.000451	CcSEcCtD
Phenytoin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	3.26e-05	0.000451	CcSEcCtD
Phenytoin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	3.26e-05	0.000451	CcSEcCtD
Phenytoin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	3.26e-05	0.00045	CcSEcCtD
Phenytoin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	3.25e-05	0.000449	CcSEcCtD
Phenytoin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.25e-05	0.000449	CcSEcCtD
Phenytoin—ABCB1—brain—acquired immunodeficiency syndrome	3.24e-05	0.0021	CbGeAlD
Phenytoin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.24e-05	0.000448	CcSEcCtD
Phenytoin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	3.24e-05	0.000448	CcSEcCtD
Phenytoin—Malaise—Lamivudine—acquired immunodeficiency syndrome	3.24e-05	0.000448	CcSEcCtD
Phenytoin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.23e-05	0.000447	CcSEcCtD
Phenytoin—Nausea—Didanosine—acquired immunodeficiency syndrome	3.23e-05	0.000447	CcSEcCtD
Phenytoin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	3.23e-05	0.000446	CcSEcCtD
Phenytoin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	3.23e-05	0.000446	CcSEcCtD
Phenytoin—Syncope—Lamivudine—acquired immunodeficiency syndrome	3.22e-05	0.000445	CcSEcCtD
Phenytoin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	3.22e-05	0.000445	CcSEcCtD
Phenytoin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	3.22e-05	0.000445	CcSEcCtD
Phenytoin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	3.22e-05	0.000444	CcSEcCtD
Phenytoin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	3.21e-05	0.000443	CcSEcCtD
Phenytoin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	3.21e-05	0.000443	CcSEcCtD
Phenytoin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	3.21e-05	0.000443	CcSEcCtD
Phenytoin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	3.21e-05	0.000443	CcSEcCtD
Phenytoin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	3.18e-05	0.00044	CcSEcCtD
Phenytoin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	3.18e-05	0.000439	CcSEcCtD
Phenytoin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	3.17e-05	0.000438	CcSEcCtD
Phenytoin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	3.16e-05	0.000436	CcSEcCtD
Phenytoin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	3.15e-05	0.000435	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	3.15e-05	0.000435	CcSEcCtD
Phenytoin—Shock—Ritonavir—acquired immunodeficiency syndrome	3.14e-05	0.000434	CcSEcCtD
Phenytoin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.14e-05	0.000433	CcSEcCtD
Phenytoin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	3.13e-05	0.000433	CcSEcCtD
Phenytoin—ABCB1—lymph node—acquired immunodeficiency syndrome	3.13e-05	0.00203	CbGeAlD
Phenytoin—Cough—Lamivudine—acquired immunodeficiency syndrome	3.13e-05	0.000433	CcSEcCtD
Phenytoin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	3.13e-05	0.000433	CcSEcCtD
Phenytoin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	3.13e-05	0.000433	CcSEcCtD
Phenytoin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	3.13e-05	0.000432	CcSEcCtD
Phenytoin—Dizziness—Stavudine—acquired immunodeficiency syndrome	3.12e-05	0.000432	CcSEcCtD
Phenytoin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	3.12e-05	0.000431	CcSEcCtD
Phenytoin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	3.12e-05	0.000431	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	3.12e-05	0.00043	CcSEcCtD
Phenytoin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	3.11e-05	0.00043	CcSEcCtD
Phenytoin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	3.11e-05	0.00043	CcSEcCtD
Phenytoin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	3.11e-05	0.00043	CcSEcCtD
Phenytoin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.1e-05	0.000428	CcSEcCtD
Phenytoin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	3.1e-05	0.000428	CcSEcCtD
Phenytoin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	3.09e-05	0.000426	CcSEcCtD
Phenytoin—Constipation—Efavirenz—acquired immunodeficiency syndrome	3.09e-05	0.000426	CcSEcCtD
Phenytoin—Rash—Nevirapine—acquired immunodeficiency syndrome	3.09e-05	0.000426	CcSEcCtD
Phenytoin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.08e-05	0.000426	CcSEcCtD
Phenytoin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	3.08e-05	0.000425	CcSEcCtD
Phenytoin—Dizziness—Abacavir—acquired immunodeficiency syndrome	3.08e-05	0.000425	CcSEcCtD
Phenytoin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	3.07e-05	0.000424	CcSEcCtD
Phenytoin—Headache—Nevirapine—acquired immunodeficiency syndrome	3.07e-05	0.000424	CcSEcCtD
Phenytoin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	3.06e-05	0.000423	CcSEcCtD
Phenytoin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	3.06e-05	0.000423	CcSEcCtD
Phenytoin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.06e-05	0.000423	CcSEcCtD
Phenytoin—Infection—Saquinavir—acquired immunodeficiency syndrome	3.05e-05	0.000422	CcSEcCtD
Phenytoin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3.04e-05	0.000421	CcSEcCtD
Phenytoin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	3.04e-05	0.00042	CcSEcCtD
Phenytoin—Urticaria—Indinavir—acquired immunodeficiency syndrome	3.03e-05	0.000419	CcSEcCtD
Phenytoin—Shock—Saquinavir—acquired immunodeficiency syndrome	3.02e-05	0.000418	CcSEcCtD
Phenytoin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	3.02e-05	0.000418	CcSEcCtD
Phenytoin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.02e-05	0.000417	CcSEcCtD
Phenytoin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	3.01e-05	0.000416	CcSEcCtD
Phenytoin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.01e-05	0.000416	CcSEcCtD
Phenytoin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	3.01e-05	0.000416	CcSEcCtD
Phenytoin—Vomiting—Stavudine—acquired immunodeficiency syndrome	3e-05	0.000415	CcSEcCtD
Phenytoin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3e-05	0.000415	CcSEcCtD
Phenytoin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	2.99e-05	0.000413	CcSEcCtD
Phenytoin—Rash—Nelfinavir—acquired immunodeficiency syndrome	2.99e-05	0.000413	CcSEcCtD
Phenytoin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	2.99e-05	0.000413	CcSEcCtD
Phenytoin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	2.98e-05	0.000412	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	2.98e-05	0.000412	CcSEcCtD
Phenytoin—Rash—Stavudine—acquired immunodeficiency syndrome	2.98e-05	0.000412	CcSEcCtD
Phenytoin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	2.98e-05	0.000411	CcSEcCtD
Phenytoin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	2.98e-05	0.000411	CcSEcCtD
Phenytoin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	2.97e-05	0.000411	CcSEcCtD
Phenytoin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	2.97e-05	0.00041	CcSEcCtD
Phenytoin—Headache—Nelfinavir—acquired immunodeficiency syndrome	2.97e-05	0.00041	CcSEcCtD
Phenytoin—Headache—Stavudine—acquired immunodeficiency syndrome	2.96e-05	0.000409	CcSEcCtD
Phenytoin—Vomiting—Abacavir—acquired immunodeficiency syndrome	2.96e-05	0.000409	CcSEcCtD
Phenytoin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	2.96e-05	0.000408	CcSEcCtD
Phenytoin—Constipation—Delavirdine—acquired immunodeficiency syndrome	2.95e-05	0.000408	CcSEcCtD
Phenytoin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	2.95e-05	0.000407	CcSEcCtD
Phenytoin—Rash—Abacavir—acquired immunodeficiency syndrome	2.93e-05	0.000406	CcSEcCtD
Phenytoin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	2.93e-05	0.000405	CcSEcCtD
Phenytoin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	2.93e-05	0.000405	CcSEcCtD
Phenytoin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	2.93e-05	0.000405	CcSEcCtD
Phenytoin—Headache—Abacavir—acquired immunodeficiency syndrome	2.92e-05	0.000403	CcSEcCtD
Phenytoin—Infection—Lamivudine—acquired immunodeficiency syndrome	2.91e-05	0.000402	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	2.91e-05	0.000402	CcSEcCtD
Phenytoin—Nausea—Nevirapine—acquired immunodeficiency syndrome	2.91e-05	0.000402	CcSEcCtD
Phenytoin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	2.91e-05	0.000401	CcSEcCtD
Phenytoin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	2.89e-05	0.000399	CcSEcCtD
Phenytoin—Shock—Lamivudine—acquired immunodeficiency syndrome	2.88e-05	0.000399	CcSEcCtD
Phenytoin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	2.87e-05	0.000397	CcSEcCtD
Phenytoin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	2.87e-05	0.000397	CcSEcCtD
Phenytoin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	2.87e-05	0.000397	CcSEcCtD
Phenytoin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	2.87e-05	0.000396	CcSEcCtD
Phenytoin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	2.87e-05	0.000396	CcSEcCtD
Phenytoin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	2.85e-05	0.000394	CcSEcCtD
Phenytoin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	2.85e-05	0.000393	CcSEcCtD
Phenytoin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	2.84e-05	0.000393	CcSEcCtD
Phenytoin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	2.84e-05	0.000392	CcSEcCtD
Phenytoin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	2.83e-05	0.000392	CcSEcCtD
Phenytoin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	2.81e-05	0.000389	CcSEcCtD
Phenytoin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	2.81e-05	0.000389	CcSEcCtD
Phenytoin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	2.81e-05	0.000388	CcSEcCtD
Phenytoin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	2.81e-05	0.000388	CcSEcCtD
Phenytoin—Nausea—Stavudine—acquired immunodeficiency syndrome	2.81e-05	0.000388	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	2.8e-05	0.000387	CcSEcCtD
Phenytoin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	2.79e-05	0.000386	CcSEcCtD
Phenytoin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	2.78e-05	0.000384	CcSEcCtD
Phenytoin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	2.78e-05	0.000384	CcSEcCtD
Phenytoin—Nausea—Abacavir—acquired immunodeficiency syndrome	2.76e-05	0.000382	CcSEcCtD
Phenytoin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	2.76e-05	0.000381	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	2.76e-05	0.000381	CcSEcCtD
Phenytoin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	2.75e-05	0.00038	CcSEcCtD
Phenytoin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	2.74e-05	0.000379	CcSEcCtD
Phenytoin—Asthenia—Indinavir—acquired immunodeficiency syndrome	2.74e-05	0.000379	CcSEcCtD
Phenytoin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	2.74e-05	0.000379	CcSEcCtD
Phenytoin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	2.74e-05	0.000379	CcSEcCtD
Phenytoin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	2.73e-05	0.000377	CcSEcCtD
Phenytoin—Constipation—Ritonavir—acquired immunodeficiency syndrome	2.73e-05	0.000377	CcSEcCtD
Phenytoin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	2.73e-05	0.000377	CcSEcCtD
Phenytoin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	2.72e-05	0.000375	CcSEcCtD
Phenytoin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	2.7e-05	0.000374	CcSEcCtD
Phenytoin—Pruritus—Indinavir—acquired immunodeficiency syndrome	2.7e-05	0.000373	CcSEcCtD
Phenytoin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	2.67e-05	0.000369	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	2.67e-05	0.000369	CcSEcCtD
Phenytoin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	2.66e-05	0.000367	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	2.65e-05	0.000367	CcSEcCtD
Phenytoin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	2.65e-05	0.000366	CcSEcCtD
Phenytoin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	2.65e-05	0.000366	CcSEcCtD
Phenytoin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	2.63e-05	0.000364	CcSEcCtD
Phenytoin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	2.63e-05	0.000364	CcSEcCtD
Phenytoin—Constipation—Saquinavir—acquired immunodeficiency syndrome	2.63e-05	0.000363	CcSEcCtD
Phenytoin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	2.61e-05	0.000361	CcSEcCtD
Phenytoin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	2.61e-05	0.000361	CcSEcCtD
Phenytoin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	2.61e-05	0.000361	CcSEcCtD
Phenytoin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	2.61e-05	0.00036	CcSEcCtD
Phenytoin—Rash—Zidovudine—acquired immunodeficiency syndrome	2.59e-05	0.000358	CcSEcCtD
Phenytoin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	2.59e-05	0.000358	CcSEcCtD
Phenytoin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	2.59e-05	0.000357	CcSEcCtD
Phenytoin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	2.58e-05	0.000357	CcSEcCtD
Phenytoin—Headache—Zidovudine—acquired immunodeficiency syndrome	2.57e-05	0.000355	CcSEcCtD
Phenytoin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	2.55e-05	0.000353	CcSEcCtD
Phenytoin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	2.55e-05	0.000352	CcSEcCtD
Phenytoin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	2.54e-05	0.000351	CcSEcCtD
Phenytoin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	2.54e-05	0.00035	CcSEcCtD
Phenytoin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	2.53e-05	0.00035	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	2.53e-05	0.00035	CcSEcCtD
Phenytoin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	2.53e-05	0.000349	CcSEcCtD
Phenytoin—Dizziness—Indinavir—acquired immunodeficiency syndrome	2.53e-05	0.000349	CcSEcCtD
Phenytoin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	2.52e-05	0.000349	CcSEcCtD
Phenytoin—Constipation—Lamivudine—acquired immunodeficiency syndrome	2.51e-05	0.000346	CcSEcCtD
Phenytoin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	2.48e-05	0.000342	CcSEcCtD
Phenytoin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.47e-05	0.000341	CcSEcCtD
Phenytoin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.44e-05	0.000338	CcSEcCtD
Phenytoin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	2.44e-05	0.000337	CcSEcCtD
Phenytoin—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.44e-05	0.000337	CcSEcCtD
Phenytoin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.43e-05	0.000336	CcSEcCtD
Phenytoin—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.43e-05	0.000336	CcSEcCtD
Phenytoin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	2.42e-05	0.000334	CcSEcCtD
Phenytoin—Rash—Indinavir—acquired immunodeficiency syndrome	2.41e-05	0.000333	CcSEcCtD
Phenytoin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.41e-05	0.000332	CcSEcCtD
Phenytoin—Headache—Indinavir—acquired immunodeficiency syndrome	2.39e-05	0.000331	CcSEcCtD
Phenytoin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	2.39e-05	0.00033	CcSEcCtD
Phenytoin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.36e-05	0.000326	CcSEcCtD
Phenytoin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2.35e-05	0.000325	CcSEcCtD
Phenytoin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	2.33e-05	0.000322	CcSEcCtD
Phenytoin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.32e-05	0.00032	CcSEcCtD
Phenytoin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.29e-05	0.000317	CcSEcCtD
Phenytoin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.29e-05	0.000317	CcSEcCtD
Phenytoin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	2.28e-05	0.000315	CcSEcCtD
Phenytoin—Rash—Efavirenz—acquired immunodeficiency syndrome	2.28e-05	0.000314	CcSEcCtD
Phenytoin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.27e-05	0.000314	CcSEcCtD
Phenytoin—Nausea—Indinavir—acquired immunodeficiency syndrome	2.27e-05	0.000313	CcSEcCtD
Phenytoin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.26e-05	0.000313	CcSEcCtD
Phenytoin—Headache—Efavirenz—acquired immunodeficiency syndrome	2.26e-05	0.000312	CcSEcCtD
Phenytoin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.26e-05	0.000312	CcSEcCtD
Phenytoin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.2e-05	0.000305	CcSEcCtD
Phenytoin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.2e-05	0.000303	CcSEcCtD
Phenytoin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.18e-05	0.000302	CcSEcCtD
Phenytoin—Rash—Delavirdine—acquired immunodeficiency syndrome	2.18e-05	0.000301	CcSEcCtD
Phenytoin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.17e-05	0.000301	CcSEcCtD
Phenytoin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.17e-05	0.0003	CcSEcCtD
Phenytoin—Headache—Delavirdine—acquired immunodeficiency syndrome	2.16e-05	0.000299	CcSEcCtD
Phenytoin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.16e-05	0.000298	CcSEcCtD
Phenytoin—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.14e-05	0.000296	CcSEcCtD
Phenytoin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	2.11e-05	0.000292	CcSEcCtD
Phenytoin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.1e-05	0.000291	CcSEcCtD
Phenytoin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.1e-05	0.000291	CcSEcCtD
Phenytoin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.07e-05	0.000287	CcSEcCtD
Phenytoin—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.05e-05	0.000283	CcSEcCtD
Phenytoin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	2.03e-05	0.000281	CcSEcCtD
Phenytoin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.03e-05	0.000281	CcSEcCtD
Phenytoin—Rash—Ritonavir—acquired immunodeficiency syndrome	2.01e-05	0.000278	CcSEcCtD
Phenytoin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.01e-05	0.000278	CcSEcCtD
Phenytoin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.01e-05	0.000277	CcSEcCtD
Phenytoin—Headache—Ritonavir—acquired immunodeficiency syndrome	2e-05	0.000276	CcSEcCtD
Phenytoin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	1.95e-05	0.00027	CcSEcCtD
Phenytoin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	1.94e-05	0.000268	CcSEcCtD
Phenytoin—Rash—Saquinavir—acquired immunodeficiency syndrome	1.94e-05	0.000268	CcSEcCtD
Phenytoin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	1.94e-05	0.000267	CcSEcCtD
Phenytoin—Headache—Saquinavir—acquired immunodeficiency syndrome	1.93e-05	0.000266	CcSEcCtD
Phenytoin—Nausea—Ritonavir—acquired immunodeficiency syndrome	1.9e-05	0.000262	CcSEcCtD
Phenytoin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	1.86e-05	0.000258	CcSEcCtD
Phenytoin—Rash—Lamivudine—acquired immunodeficiency syndrome	1.85e-05	0.000255	CcSEcCtD
Phenytoin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	1.85e-05	0.000255	CcSEcCtD
Phenytoin—Headache—Lamivudine—acquired immunodeficiency syndrome	1.84e-05	0.000254	CcSEcCtD
Phenytoin—Nausea—Saquinavir—acquired immunodeficiency syndrome	1.83e-05	0.000252	CcSEcCtD
Phenytoin—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.74e-05	0.000241	CcSEcCtD
